Mia's Feed
Medical News & Research

Start of Ebola Vaccination Campaign in Southern Congo

Start of Ebola Vaccination Campaign in Southern Congo

Share this article

Vaccination has begun in southern Congo to combat a recent Ebola outbreak with over 68 suspected cases and 16 fatalities. The WHO is deploying vaccines and addressing access challenges to control the virus.

2 min read

In a significant step to combat the ongoing Ebola outbreak, vaccination efforts have commenced in the southern region of Congo's Kasai province. The World Health Organization (WHO) announced that initial vaccinations target those exposed to the virus as well as frontline healthcare workers. The outbreak, characterized by its high contagion level, was officially declared earlier this month in the remote area of Bulape. So far, at least 16 fatalities have been reported, alongside 68 suspected cases, highlighting the severity of the situation.

The vaccination campaign is utilizing the Ervebo vaccine, with the first batch comprising 400 doses already dispatched to the region. Further vaccine supplies are anticipated as the International Coordinating Group on Vaccine Provision has approved an additional approximately 45,000 doses, supplementing the initial stockpile of 2,000 doses available in the country. However, challenges such as limited access to affected areas and scarce financial resources have hampered vaccination efforts.

This particular outbreak marks Congo’s 16th since the virus was first identified in 1976 and involves the Zaire species of Ebola, named after the country's former name. The situation is compounded by ongoing conflict and violence, especially in the eastern parts of the country, which have severely affected the health infrastructure. Despite these obstacles, health authorities continue to work diligently to contain the virus and prevent further spread.

Source: https://medicalxpress.com/news/2025-09-ebola-vaccination-southern-congo.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Impacts of the 'One Big Beautiful Bill' on Older Adults' Healthcare

Explore how the recent healthcare legislation, 'One Big Beautiful Bill', will affect older adults' access to Medicare, Medicaid, and long-term care services in the USA.

Targeting SUMO2 Protein with Blocker Drugs Shows Promise Against Synovial Sarcoma

New research uncovers the potential of SUMO2 protein inhibitors like TAK-981 as a targeted therapy for synovial sarcoma, offering hope for improved treatment options in this rare cancer.

Sun Safety Tips: Expert Advice from a Dermatologist to Protect Your Skin

Learn essential sun safety tips from a dermatologist to prevent skin damage and reduce skin cancer risks through effective sunscreen use, protective clothing, and awareness of UV exposure.

FDA Approves Injectable Leqembi for Early Alzheimer's Disease Treatment

The FDA has approved Leqembi Iqlik, a new subcutaneous injectable for early Alzheimer's disease, offering a faster, more convenient treatment option for patients after initial IV therapy.